The Moscow office of Clifford Chance has formed part of a multi-jurisdictional team helping GE obtain US and global merger clearance in connection with the USD 21.4 billion sale of its BioPharma business to Danaher.
The deal was reviewed by antitrust authorities in eight jurisdictions and was cleared by all: the European Commission, Brazil's CADE, China's SAMR, the Japan Fair Trade Commission, the Korean Fair Trade Commission, the Israeli Competition Authority, the Russian Federal Antimonopoly Service, and the US Federal Trade Commission.
Clifford Chance's team included Partners Sharis Pozen from Washington D.C., Marc Besen from Dusseldorf, Anastasios Tomtsis from Brussels, Bai Yong from Beijing, and Torsten Syrbe from Moscow.
Editor's note: After this article was published, Alrud informed CEE Legal Matters that it had acted as local advisor in Russia to the Danaher Corporation on the deal. The firm's team included Partner German Zakharov and Senior Associate Ruslana Karimova.
